Sarah Nikiforow, MD, PhD - 2022 World Medical Innovation Forum
Sarah Nikiforow
This speaker appears at this event:

Sarah Nikiforow, MD, PhD

Medical Director, Cell Manipulation Core Facility, Technical Director, Immune Effector Cell Therapy Program, DFCI

Assistant Professor, HMS

Dr. Nikiforow is currently an Assistant Professor at Harvard Medical School with the Stem Cell Transplant Program at Dana-Farber Cancer Institute, Medical Director of the Cell Manipulation Core Facility (CMCF), and Technical Director of DFCI’s Immune Effector Cell Program.  Dr. Nikiforow earned her MD and a PhD in Immunobiology at Yale University working on the differential roles of CD4 and CD8 T cells in immune control over Epstein-Barr virus-induced B-cell transformation.

Dr. Nikiforow has pursued a translational research career focusing on immune reconstitution after stem cell transplant and therapeutic use of adoptive cellular products.  Through the CMCF and as Principal Investigator of Phase I and II clinical trials, she is working to bring cellular therapies such as chimeric antigen-receptor T cells, genetically-modified stem cells, and regulatory T-cell infusions into the clinic at Dana-Farber.  Her work with the International Society of Cellular Therapy, the Foundation for the Accreditation of Cellular Therapy and the Center for International Blood & Marrow Transplant Research have promoted education and set standards for safe implementation of new approaches within the broader and ever-growing cellular therapy field.